ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for James M Daly. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at James M Daly har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MDGL / Madrigal Pharmaceuticals, Inc. Director 2.627
US:ACAD / ACADIA Pharmaceuticals Inc. Director 34.041
US:HALO / Halozyme Therapeutics, Inc. Director 20.503
US:BLCM / Bellicum Pharmaceuticals, Inc. Director 109.873
US:CMRX / Chimerix, Inc. Director 21.000
US:INCY / Incyte Corporation EVP, Chief Commercial Officer 17.662
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af James M Daly. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACAD / ACADIA Pharmaceuticals Inc. Insider Trades
Insidersalg ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-05-11 ACAD Daly James M 26.250 51,1306 26.250 51,1306 1.342.178 359 19.4 -832.928 -62,06
2019-09-09 ACAD Daly James M 29.600 37,7873 29.600 37,7873 1.118.504
2019-09-09 ACAD Daly James M 400 38,3900 400 38,3900 15.356

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACAD / ACADIA Pharmaceuticals Inc. Insider Trades
Insiderkøb HALO / Halozyme Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insidersalg HALO / Halozyme Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-08-14 HALO Daly James M 10.000 43,7410 10.000 43,7410 437.410 72 33.3200 -104.210 -23,82
2023-08-11 HALO Daly James M 10.000 43,7110 10.000 43,7110 437.110
2020-11-25 HALO Daly James M 10.363 40,4130 10.363 40,4130 418.800
2020-08-13 HALO Daly James M 34.337 29,1200 34.337 29,1200 999.893

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insiderkøb MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
Insidersalg MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-02-27 MDGL Daly James M 398 346,9031 398 346,9031 138.067 85 267.5600 -31.578 -22,87
2025-02-27 MDGL Daly James M 14.302 347,3900 14.302 347,3900 4.968.372
2025-02-27 MDGL Daly James M 770 348,9433 770 348,9433 268.686

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af James M Daly som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-24 2025-06-20 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 715 2.627 37,40
2025-06-02 2025-05-29 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 9.387 34.041 38,07
2025-02-28 2025-02-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale -770 1.912 -28,71 348,94 -268.686 667.180
2025-02-28 2025-02-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale -14.302 2.682 -84,21 347,39 -4.968.372 931.700
2025-02-28 2025-02-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale -398 16.984 -2,29 346,90 -138.067 5.891.802
2025-02-28 2025-02-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.000 17.382 52,71 111,06 666.360 1.930.445
2025-02-28 2025-02-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.470 11.382 495,29 65,06 616.118 740.513
2024-06-27 2024-06-25 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 714 1.912 59,60
2024-05-31 2024-05-29 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.652 24.654 36,95
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 1.198 -14,31 248,45 -49.690 297.644
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -43 1.398 -2,98 247,03 -10.622 345.354
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -557 1.441 -27,88 246,30 -137.187 354.912
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.991 1.998 -59,95 244,89 -732.480 489.299
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.279 4.989 -55,72 244,19 -1.533.286 1.218.277
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -842 11.268 -6,95 243,26 -204.821 2.741.007
2024-04-03 2024-04-02 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.912 12.110 910,85 105,08 1.146.633 1.272.519
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -274 1.198 -18,61 266,91 -73.132 319.752
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -500 1.472 -25,35 265,49 -132.743 390.795
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -351 1.972 -15,11 264,89 -92.977 522.365
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -178 2.323 -7,12 263,31 -46.870 611.677
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 2.501 -24,24 262,00 -209.604 655.275
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 3.301 -5,71 259,11 -51.822 855.322
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.460 3.501 -29,43 258,28 -377.094 904.250
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.604 4.961 -42,08 257,30 -927.302 1.276.456
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.401 8.565 -46,35 256,50 -1.898.371 2.196.939
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.809 15.966 -29,90 255,64 -1.740.630 4.081.494
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.577 22.775 7,44 105,08 165.711 2.393.197
2024-04-03 2024-04-01 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20.000 21.198 1.669,45 100,45 2.009.000 2.129.339
2023-08-15 2023-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -10.000 20.503 -32,78 43,74 -437.410 896.822
2023-08-15 2023-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -10.000 30.503 -24,69 43,71 -437.110 1.333.317
2023-06-20 2023-06-15 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Common Stock
A - Award 1.198 1.198
2023-06-05 2023-06-01 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 8.552 18.002 90,50
2023-06-05 2022-06-07 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.391 9.450 208,92
2023-06-05 2021-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 3.059 3.059
2023-05-09 2023-05-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8.065 40.503 24,86
2023-01-05 2023-01-03 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 60.414 109.873 122,15
2022-09-02 2022-09-01 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 35.082 49.459 244,01
2022-05-06 2022-05-05 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Unit
A - Award 6.206 32.438 23,66
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
M - Exercise -809 0 -100,00
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
M - Exercise -13.568 0 -100,00
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 809 14.377 5,96
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 13.568 13.568
2021-07-07 2021-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 6.500 6.500
2021-07-06 2021-07-01 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
A - Award 809 809
2021-06-24 2021-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Restricted Stock Units
A - Award 6.391 6.391
2021-06-24 2021-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Director Stock Options (Right to Buy)
A - Award 11.637 11.637
2021-06-21 2021-06-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 12.489 12.489
2021-05-06 2021-05-05 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Unit
A - Award 5.230 26.232 24,90
2021-01-05 2021-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
A - Award 13.568 13.568
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -10.363 21.002 -33,04 40,41 -418.800 848.754
2020-08-13 2020-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -34.337 31.365 -52,26 29,12 -999.893 913.349
2020-06-25 2020-06-23 4 ACAD ACADIA PHARMACEUTICALS INC
Restricted Stock Units
A - Award 3.059 3.059
2020-06-25 2020-06-23 4 ACAD ACADIA PHARMACEUTICALS INC
Director Stock Options (Right to Buy)
A - Award 5.579 5.579
2020-06-18 2020-06-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 6.000 6.000
2020-06-16 2020-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 6.500 6.500
2020-05-13 2020-05-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2020-05-13 2020-05-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -11.250 11.250 -50,00
2020-05-13 2020-05-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale -26.250 0 -100,00 51,13 -1.342.178
2020-05-13 2020-05-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 15.000 26.250 133,33 27,25 408.750 715.312
2020-05-13 2020-05-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 11.250 11.250 25,24 283.950 283.950
2020-05-01 2020-04-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8.829 65.702 15,52
2019-09-11 2019-09-09 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -30.000 0 -100,00
2019-09-11 2019-09-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale -400 0 -100,00 38,39 -15.356
2019-09-11 2019-09-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale -29.600 400 -98,67 37,79 -1.118.504 15.115
2019-09-11 2019-09-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 30.000 17,52 525.600 525.600
2019-07-01 2019-06-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2019-06-28 2019-06-26 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award -22.500 22.500 -50,00
2019-06-24 2019-06-20 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 21.000 21.000
2019-06-14 2019-06-13 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 25.000 25.000
2019-05-03 2019-05-02 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 12.173 56.873 27,23
2018-06-21 2018-06-20 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 21.000 21.000
2018-06-18 2018-06-14 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2018-06-08 2018-06-06 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2018-06-08 2018-06-06 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2018-05-02 2018-05-02 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 10.363 44.700 30,18
2017-07-19 2017-07-17 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2017-06-29 2017-06-28 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 21.000 21.000
2017-06-15 2017-06-14 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2017-06-14 2017-06-13 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2017-05-05 2017-05-04 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 14.135 34.337 69,97
2016-06-28 2016-06-24 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 9.000 9.000
2016-06-17 2016-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2016-06-10 2016-06-10 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 12.500 12.500
2016-05-19 2016-05-17 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 833 833
2016-05-19 2016-05-17 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 20.000 20.000
2016-05-06 2016-05-04 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 20.202 20.202
2016-01-11 2016-01-07 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -981 17.662 -5,26
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -601 2.407 -19,98
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.331 30.928 -19,16
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 16.765 -14,21
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
S - Sale -981 3.521 -21,79 107,84 -105.791 379.705
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 981 4.502 27,86 64,55 63.324 290.604
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
S - Sale -10.710 3.521 -75,26 108,28 -1.159.679 381.254
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 601 14.231 4,41 16,62 9.989 236.519
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.331 13.630 116,38 16,62 121.841 226.531
2015-06-25 2015-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 6.299 78,90 18,32 50.893 115.398
2015-06-24 2015-06-22 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 9.000 9.000
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -981 18.643 -5,00
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -602 3.008 -16,68
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.732 38.659 -16,67
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 19.543 -12,45
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -981 3.521 -21,79 106,00 -103.986 373.226
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
M - Exercise 981 4.502 27,86 64,55 63.324 290.604
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
S - Sale -11.112 3.521 -75,94 106,43 -1.182.650 374.740
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
M - Exercise 602 14.633 4,29 16,62 10.005 243.200
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.732 14.031 122,75 16,62 128.506 233.195
2015-05-28 2015-05-26 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 6.299 78,90 18,32 50.893 115.398
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -14.718 19.624 -42,86
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -5.556 22.321 -19,93
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -15.464 46.391 -25,00
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -1.203 3.610 -24,99
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
S - Sale -14.718 3.521 -80,70 107,67 -1.584.687 379.106
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 14.718 18.239 418,01 64,55 950.047 1.177.327
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
S - Sale -22.223 3.521 -86,32 107,67 -2.392.750 379.106
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 5.556 25.744 27,52 18,32 101.786 471.630
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 15.464 20.188 327,35 16,62 257.012 335.525
2015-04-24 2015-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.203 4.724 34,17 16,62 19.994 78.513
2015-02-25 2015-02-24 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -602 4.813 -11,12
2015-02-25 2015-02-24 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.732 61.855 -11,11
2015-02-25 2015-02-24 4 INCY INCYTE CORP
Common Stock
S - Sale -8.334 3.521 -70,30 81,77 -681.471 287.912
2015-02-25 2015-02-24 4 INCY INCYTE CORP
Common Stock
M - Exercise 602 11.855 5,35 16,62 10.005 197.030
2015-02-25 2015-02-24 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.732 11.253 219,60 16,62 128.506 187.025
2015-02-25 2015-02-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 27.877 -9,06
2015-02-25 2015-02-23 4 INCY INCYTE CORP
Common Stock
S - Sale -2.778 3.521 -44,10 83,44 -231.796 293.792
2015-02-25 2015-02-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 6.299 78,90 18,32 50.893 115.398
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.777 30.655 -8,31
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -601 5.415 -9,99
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.731 69.587 -10,00
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.109 3.521 -75,93 77,68 -862.947 273.511
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.777 14.630 23,43 18,32 50.875 268.022
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 601 11.853 5,34 16,62 9.989 196.997
2015-01-26 2015-01-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.731 11.252 219,57 16,62 128.489 187.008
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 1.099 1.099
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 20.446 20.446
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Common Stock
A - Award 3.022 3.521 605,61
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -502 6.016 -7,70
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.833 77.318 -9,20
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 33.432 -7,67
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.113 0 -100,00 74,43 -827.141
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 502 11.113 4,73 16,62 8.343 184.698
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.833 10.611 281,97 16,62 130.184 176.355
2014-12-29 2014-12-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -501 6.518 -7,14
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 85.151 -8,42
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 36.210 -7,13
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 74,08 -823.103
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Common Stock
M - Exercise 501 11.111 4,72 16,62 8.327 184.665
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.610 281,93 16,62 130.168 176.338
2014-11-26 2014-11-24 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -501 7.019 -6,66
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 92.983 -7,77
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 38.988 -6,65
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 53,49 -594.327
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 501 11.111 4,72 16,62 8.327 184.665
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.610 281,93 16,62 130.168 176.338
2014-10-24 2014-10-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -502 7.520 -6,26
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 100.815 -7,21
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.777 41.766 -6,23
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 47,65 -529.439
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 502 11.111 4,73 16,62 8.343 184.665
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.609 282,03 16,62 130.168 176.322
2014-09-25 2014-09-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.777 2.777 18,32 50.875 50.875
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -501 8.022 -5,88
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 108.647 -6,72
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 44.543 -5,87
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 51,96 -577.328
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 501 11.111 4,72 16,62 8.327 184.665
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.610 281,93 16,62 130.168 176.338
2014-08-27 2014-08-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -501 8.523 -5,55
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 116.479 -6,30
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 47.231 -5,56
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 48,54 -539.328
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 501 11.111 4,72 16,62 8.327 184.665
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.610 281,93 16,62 130.168 176.338
2014-07-25 2014-07-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -502 9.024 -5,27
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 124.311 -5,93
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.777 50.099 -5,25
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Common Stock
S - Sale -8.334 0 -100,00 55,92 -466.037
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 502 8.334 6,41 16,62 8.343 138.511
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 7.832 16,62 130.168 130.168
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Common Stock
S - Sale -2.777 0 -100,00 56,38 -156.567
2014-06-25 2014-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.777 2.777 18,32 50.875 50.875
2014-06-23 2014-06-20 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 18.000 18.000
2014-06-23 2014-06-20 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 9.000 9.000
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -501 9.526 -5,00
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.832 132.143 -5,60
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -2.778 52.876 -4,99
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Common Stock
S - Sale -11.111 0 -100,00 48,48 -538.661
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 501 11.111 4,72 16,62 8.327 184.665
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.832 10.610 281,93 16,62 130.168 176.338
2014-05-28 2014-05-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.778 2.778 18,32 50.893 50.893
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -1.504 10.027 -13,04
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -23.496 139.975 -14,37
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -5.555 55.654 -9,08
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Common Stock
S - Sale -30.555 0 -100,00 47,71 -1.457.779
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.504 30.555 5,18 16,62 24.996 507.824
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 23.496 29.051 422,97 16,62 390.504 482.828
2014-04-25 2014-04-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 5.555 5.555 18,32 101.768 101.768
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -118.481 163.471 -42,02
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -6.517 11.531 -36,11
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -33.333 61.209 -35,26
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Common Stock
S - Sale -158.331 0 -100,00 66,49 -10.527.428
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Common Stock
M - Exercise 118.481 158.331 297,32 16,62 1.969.154 2.631.461
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Common Stock
M - Exercise 6.517 39.850 19,55 16,62 108.313 662.307
2014-02-18 2014-02-13 4 INCY INCYTE CORP
Common Stock
M - Exercise 33.333 33.333 18,32 610.661 610.661
2014-01-23 2014-01-21 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 34.342 34.342
2014-01-23 2014-01-21 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 982 982
2013-02-12 2013-02-09 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 94.542 94.542
2013-02-12 2013-02-09 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 5.458 5.458
2012-10-23 2012-10-22 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 281.952 281.952
2012-10-23 2012-10-22 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 18.048 18.048
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)